China Universal Asset Management Company’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-256
Closed -$20K – 489
2025
Q2
$20K Hold
256
– – ﹤0.01% 452
2025
Q1
$18.6K Hold
256
– – ﹤0.01% 458
2024
Q4
$19K Hold
256
– – ﹤0.01% 486
2024
Q3
$16.9K Hold
256
– – ﹤0.01% 410
2024
Q2
$23.6K Hold
256
– – ﹤0.01% 388
2024
Q1
$24.5K Hold
256
– – ﹤0.01% 423
2023
Q4
$19.5K Hold
256
– – ﹤0.01% 410
2023
Q3
$17.7K Hold
256
– – 0.01% 304
2023
Q2
$24.1K Hold
256
– – 0.01% 251
2023
Q1
$21.2K Hold
256
– – 0.01% 213
2022
Q4
$19.1K Hold
256
– – 0.01% 177
2022
Q3
$21K Sell
256
-11,465
-98% -$1.1M 0.01% 154
2022
Q2
$1.11M Buy
11,721
+5,820
+99% +$603K 0.47% 56
2022
Q1
$695K Sell
5,901
-3,797
-39% -$426K 0.25% 61
2021
Q4
$1.26M Buy
+9,698
New +$1.13M 0.3% 66

Other funds holding EW

China Universal Asset Management Company's EW Position: Q3 2025 in Review

China Universal Asset Management Company sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 256 shares — an estimated $20K sold.

China Universal Asset Management Company first reported a position in EW in Q4 2021 and held it in 15 quarters. The position peaked at $1.26M in Q4 2021. 1,255 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • China Universal Asset Management Company reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • China Universal Asset Management Company sold 256 Edwards Lifesciences shares in Q3 2025, an estimated $20K.
  • China Universal Asset Management Company first reported a position in Edwards Lifesciences in Q4 2021 and held it in 15 quarters.
  • China Universal Asset Management Company's Edwards Lifesciences position peaked at $1.26M in Q4 2021.
  • 1,255 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on China Universal Asset Management Company's 13F filing for Q3 2025, filed 10 Nov 2025.